{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T15:58:21Z","timestamp":1792857501468,"version":"4.5.0"},"reference-count":41,"publisher":"SAGE Publications","issue":"10","license":[{"start":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T00:00:00Z","timestamp":1754956800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T00:00:00Z","timestamp":1754956800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Mult Scler"],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>This randomised controlled trial investigated the effect of a personalised digital lifestyle management application (\u2018levidex\u2019) on inflammatory disease activity in newly diagnosed people with MS (pwMS), compared to a non-personalised application (\u2018dexilev\u2019) that covered similar lifestyle-related content.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      Participants (\n                      <jats:italic>N<\/jats:italic>\n                      = 234) were recruited from July 2019 to April 2022 in 20 study centres in Germany and randomised to levidex (intervention group (IG),\n                      <jats:italic>n<\/jats:italic>\n                      = 115) or \u2018dexilev\u2019 (control group (CG),\n                      <jats:italic>n<\/jats:italic>\n                      = 119). Follow-up data was collected over 1-2 years. The combined primary endpoint (new T2 lesion and\/or relapse) was analysed using Cox proportional hazards regression. Key secondary endpoints included self-reported quality of life and health behaviour.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      There was no difference in the time to the first relapse and\/or new T2 lesion between IG and CG (Hazard Ratio: 0.91; 95% confidence interval [CI]: [0.66, 1.27],\n                      <jats:italic>p<\/jats:italic>\n                      = 0.596). After 3 months, self-reported diet quality was higher in the IG (0.43; 95% CI: [0.14, 0.72],\n                      <jats:italic>p<\/jats:italic>\n                      = 0.0037). There was no difference in other secondary endpoints between IG and CG after 3 and 12 months.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>This study failed to meet its primary endpoint and usage of levidex did not differ from dexilev in its effects on inflammatory disease activity or behaviour change in this cohort of pwMS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/13524585251356410","type":"journal-article","created":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T01:14:28Z","timestamp":1755047668000},"page":"1231-1242","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":6,"title":["Digital lifestyle management application (levidex) for empowerment and health behaviour change in early multiple sclerosis \u2013 Results of the randomised controlled POWER@MS1 trial"],"prefix":"10.1177","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6681-7054","authenticated-orcid":false,"given":"Nicole","family":"Krause","sequence":"first","affiliation":[{"name":"Institute of Neuroimmunology and Multiple Sclerosis (INIMS), University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9542-4647","authenticated-orcid":false,"given":"Carlotta","family":"Derad","sequence":"additional","affiliation":[{"name":"Department of Medical Statistics, University Medical Centre G\u00f6ttingen, G\u00f6ttingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3820-9059","authenticated-orcid":false,"given":"Barbara","family":"von Glasenapp","sequence":"additional","affiliation":[{"name":"Institute of Neuroimmunology and Multiple Sclerosis (INIMS), University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0779-2640","authenticated-orcid":false,"given":"Karin","family":"Riemann-Lorenz","sequence":"additional","affiliation":[{"name":"Institute of Neuroimmunology and Multiple Sclerosis (INIMS), University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1100-0260","authenticated-orcid":false,"given":"Bj\u00f6rn","family":"Meyer","sequence":"additional","affiliation":[{"name":"Research and Development Department, GAIA Group, Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1317-2138","authenticated-orcid":false,"given":"Thomas","family":"Asendorf","sequence":"additional","affiliation":[{"name":"Department of Medical Statistics, University Medical Centre G\u00f6ttingen, G\u00f6ttingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herbert","family":"Temmes","sequence":"additional","affiliation":[{"name":"German Multiple Sclerosis Society, Federal Association, Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"van de Loo","sequence":"additional","affiliation":[{"name":"German Multiple Sclerosis Society, Federal Association, Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan M","family":"Gold","sequence":"additional","affiliation":[{"name":"Institute of Neuroimmunology and Multiple Sclerosis (INIMS), University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany"},{"name":"Klinik f\u00fcr Psychiatrie und Psychotherapie und Medizinische Klinik m.S. Psychosomatik, Campus Benjamin Franklin, Charit\u00e9\u2013Universit\u00e4tsmedizin Berlin, Berlin, Germany"},{"name":"German Center for Mental Health (DZPG), partner site Berlin\/Potsdam, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Schubert","sequence":"additional","affiliation":[{"name":"Institute of Neuroimmunology and Multiple Sclerosis (INIMS), University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2199-3315","authenticated-orcid":false,"given":"Klarissa H","family":"St\u00fcrner","sequence":"additional","affiliation":[{"name":"Department of Neurology, Christian-Albrechts-Universit\u00e4t zu Kiel, Kiel, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3510-9255","authenticated-orcid":false,"given":"Clemens","family":"Warnke","sequence":"additional","affiliation":[{"name":"Clinic and Polyclinic of Neurology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany"},{"name":"Department of Neurology at the Medical Faculty, Philipps-University Marburg, Marburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Schmidt","sequence":"additional","affiliation":[{"name":"Neurologische Gemeinschaftspraxis, Gesundheitszentrum St. Johannes Hospital, Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5347-7441","authenticated-orcid":false,"given":"Tim","family":"Friede","sequence":"additional","affiliation":[{"name":"Department of Medical Statistics, University Medical Centre G\u00f6ttingen, G\u00f6ttingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8131-9467","authenticated-orcid":false,"given":"Christoph","family":"Heesen","sequence":"additional","affiliation":[{"name":"Institute of Neuroimmunology and Multiple Sclerosis (INIMS), University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the POWER@MS1 study group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,8,12]]},"reference":[{"key":"e_1_3_3_2_2","volume-title":"Conference presentation at ECTRIMS","author":"Montalban X","unstructured":"Montalban X. Revised McDonald criteria: A new era in MS Diagnosis & management. In: Conference presentation at ECTRIMS 2024 18 September, Copenhagen, Denmark."},{"key":"e_1_3_3_3_2","unstructured":"Hemmer B Gehring K et al. Diagnose und Therapie der Multiplen Sklerose Neuromyelitis-optica-Spektrum-Erkrankungen und MOG-IgG-assoziierten Erkrankungen S2k-Leitlinie 2024. www.dgn.org\/leitlinien"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0133279"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.2196\/10050"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1186\/s11556-024-00362-7"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2024.1387658"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-021-10935-6"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000201371"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2017.33"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3182616ff9"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1177\/13524585221146430"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-041720"},{"key":"e_1_3_3_14_2","article-title":"\u2018That would have been the perfect thing after diagnosis\u2019: Development of a digital lifestyle management application in multiple sclerosis","volume":"15","author":"Krause N","year":"2022","unstructured":"Krause N, Riemann-Lorenz K, Rahn AC, et al. \u2018That would have been the perfect thing after diagnosis\u2019: Development of a digital lifestyle management application in multiple sclerosis. Ther Adv Neurol Diso 2022; 15: 17562864221118729.","journal-title":"Ther Adv Neurol Diso"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.33.11.1444"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1177\/135245850100700208"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1983.tb09716.x"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2017.09.020"},{"issue":"3","key":"e_1_3_3_19_2","first-page":"21","article-title":"The Control Preferences Scale","volume":"29","author":"Degner LF","year":"1997","unstructured":"Degner LF, Sloan JA, Venkatesh P. The Control Preferences Scale. Can J Nurs Res 1997; 29(3): 21\u201343.","journal-title":"Can J Nurs Res"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1475-6773.2004.00269.x"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1348\/135910705X53155"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1089\/acm.2009.0381"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0005-7916(00)00012-4"},{"key":"e_1_3_3_24_2","article-title":"Godin Leisure-Time Exercise Questionnaire","volume":"29","author":"Shephard R","year":"1997","unstructured":"Shephard R. Godin Leisure-Time Exercise Questionnaire. Med Sci Sports Exerc 1997; 29(suppl 6): S36\u2013S38.","journal-title":"Med Sci Sports Exerc"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1026\/0943-8149\/a000137"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.3390\/nu14112359"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-018-1113-8"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1037\/a0012983"},{"key":"e_1_3_3_29_2","unstructured":"R Core Team. R: A language and environment for statistical computing. Vienna Austria: R Foundation for Statistical Computing 2022. https:\/\/www.R-project.org\/"},{"issue":"3","key":"e_1_3_3_30_2","first-page":"1","article-title":"Mice: Multivariate imputation by chained equations in R","volume":"45","author":"van Buuren S","year":"2011","unstructured":"van Buuren S, Groothuis-Oudshoorn K. Mice: Multivariate imputation by chained equations in R. J Stat Softw 2011; 45(3): 1\u201367.","journal-title":"J Stat Softw"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2023.105043"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2022-329685"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291716002270"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1080\/16506073.2011.616531"},{"key":"e_1_3_3_35_2","volume-title":"The Behaviour Change Wheel. A Guide to Designing Interventions","author":"Michie S","year":"2014","unstructured":"Michie S, Atkins L, West R. The Behaviour Change Wheel. A Guide to Designing Interventions. Sutton: Silverback Publishing, 2014."},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1093\/tbm\/ibx019"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-244X-14-5"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.apmr.2017.12.013"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pec.2021.01.011"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1177\/13524585231201089"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-024-03843-5"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1002\/wps.21088"}],"container-title":["Multiple Sclerosis Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/13524585251356410","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/13524585251356410","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/13524585251356410","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T04:18:58Z","timestamp":1777695538000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/13524585251356410"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,12]]},"references-count":41,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["10.1177\/13524585251356410"],"URL":"https:\/\/doi.org\/10.1177\/13524585251356410","relation":{},"ISSN":["1352-4585","1477-0970"],"issn-type":[{"value":"1352-4585","type":"print"},{"value":"1477-0970","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,12]]}}}